Published in Cold Spring Harb Perspect Biol on January 29, 2015
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun (2015) 1.17
Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol (2017) 0.99
Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol (2016) 0.96
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science (2017) 0.85
Glial Contributions to Neural Function and Disease. Mol Cell Proteomics (2015) 0.78
Pediatric gliomas as neurodevelopmental disorders. Glia (2015) 0.77
Survival and proliferation of neural progenitor derived glioblastomas under hypoxic stress is controlled by a CXCL12/CXCR4 autocrine positive feedback mechanism. Clin Cancer Res (2016) 0.76
Inhibition of Nucleotide Synthesis Targets Brain Tumor Stem Cells in a Subset of Glioblastoma. Mol Cancer Ther (2016) 0.75
Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression. Mol Cancer Res (2017) 0.75
Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis. J Neurooncol (2016) 0.75
Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas. Genes (Basel) (2017) 0.75
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci (2008) 17.27
Mammalian neural stem cells. Science (2000) 16.09
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell (1999) 15.87
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 15.16
A restricted cell population propagates glioblastoma growth after chemotherapy. Nature (2012) 8.88
Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron (2011) 8.06
Cells of origin in cancer. Nature (2011) 6.85
Malignant glioma: genetics and biology of a grave matter. Genes Dev (2001) 6.78
Cancer drug resistance: an evolving paradigm. Nat Rev Cancer (2013) 6.77
A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature (1983) 6.52
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (2014) 6.09
Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell (2005) 5.51
Neural stem cells and the origin of gliomas. N Engl J Med (2005) 5.43
Mosaic analysis with double markers in mice. Cell (2005) 5.32
The mystery and magic of glia: a perspective on their roles in health and disease. Neuron (2008) 5.32
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet (2000) 5.28
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell (2009) 4.82
Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell (2011) 4.78
Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science (2000) 4.65
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev (2001) 4.53
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron (2007) 4.47
NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development (2007) 4.21
Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci (2005) 3.97
Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci (2009) 3.72
NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci (2003) 3.69
Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med (2003) 3.56
Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet (2001) 3.13
Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci U S A (2000) 2.92
Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell (2011) 2.87
Local generation of glia is a major astrocyte source in postnatal cortex. Nature (2012) 2.87
Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res (2004) 2.75
Glial specification in the vertebrate neural tube. Nat Rev Neurosci (2004) 2.75
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol (2004) 2.66
Functional genomic analysis of oligodendrocyte differentiation. J Neurosci (2006) 2.64
Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell (2012) 2.50
Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci (2008) 2.49
Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci (2006) 2.43
The molecular and genetic basis of neurological tumours. Nat Rev Cancer (2002) 2.41
Astrocytes and disease: a neurodevelopmental perspective. Genes Dev (2012) 2.28
Identification of an adult-specific glial progenitor cell. Development (1989) 2.24
Identification of neural stem cells in the adult vertebrate brain. Brain Res Bull (2002) 2.21
Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proc Natl Acad Sci U S A (2009) 2.11
Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res (1998) 1.99
Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene (2009) 1.96
Non-stem cell origin for oligodendroglioma. Cancer Cell (2010) 1.95
Development of a method for the purification and culture of rodent astrocytes. Neuron (2011) 1.92
Modeling Adult Gliomas Using RCAS/t-va Technology. Transl Oncol (2009) 1.89
Radial glial cells defined and major intermediates between embryonic stem cells and CNS neurons. Neuron (2005) 1.87
Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS One (2011) 1.77
Proliferating bipotential glial progenitor cells in adult rat optic nerve. Nature (1986) 1.76
Control of oligodendrocyte number in the developing rat optic nerve. Neuron (1994) 1.68
Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J (2009) 1.66
Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biol (1997) 1.66
Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat Neurosci (2013) 1.62
Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist (2007) 1.57
Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res (2003) 1.46
Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J Neurosci Res (1997) 1.38
NG2+/Olig2+ cells are the major cycle-related cell population of the adult human normal brain. Brain Pathol (2009) 1.37
Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. J Neurobiol (2001) 1.36
Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. Proc Natl Acad Sci U S A (1999) 1.36
The interface between glial progenitors and gliomas. Acta Neuropathol (2008) 1.33
Reconstitution of a developmental clock in vitro: a critical role for astrocytes in the timing of oligodendrocyte differentiation. Cell (1985) 1.30
Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM). Proc Natl Acad Sci U S A (2007) 1.29
Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci U S A (2001) 1.29
Gliogenesis in the central nervous system. Glia (2000) 1.24
Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res (2013) 1.23
Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS One (2008) 1.20
Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model. Cancer Res (2011) 1.17
The in vitro differentiation of a bipotential glial progenitor cell. EMBO J (1984) 1.16
SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J Clin Invest (2011) 1.16
Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives. Int J Dev Neurosci (2001) 1.12
Radioautographic investigation of gliogenesis in the corpus callosum of young rats. I. Sequential changes in oligodendrocytes. J Comp Neurol (1978) 1.06
The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn (2012) 1.02
Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation. Stem Cells (2009) 1.01
Developmental origins of brain tumors. Curr Opin Neurobiol (2012) 0.89
Evolutionary etiology of high-grade astrocytomas. Proc Natl Acad Sci U S A (2013) 0.89
Differential transformation capacity of neuro-glial progenitors during development. Proc Natl Acad Sci U S A (2013) 0.85
Akt and c-Myc induce stem-cell markers in mature primary p53⁻/⁻ astrocytes and render these cells gliomagenic in the brain of immunocompetent mice. PLoS One (2013) 0.83
Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma. J Neuropathol Exp Neurol (2012) 0.82
Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner. Glia (2013) 0.78